As a Florida lawyer who sues kidney dialysis centers, I want you to know about the recent investigation into Fresenius Medical Care and their dialysis products GranuFlo and NaturaLyte. Dialysis is a medical procedure that takes the place of the kidneys in clearing waste from the blood. The process includes adding bicarbonate to the system to neutralize acid blood buildup.
Fresenius is a German company that provides dialysis care to hundreds of thousands of Americans at its clinics. It also manufactures and distributes dialysis machines and bicarbonate products to other independent clinics. GranuFlo is a bicarbonate dialysis product made by Fresenius. Unfortunately, GranuFlo contains more of bicarbonate than its competitors and has now been linked to an increase in patient injury and death. Patients using GranuFlo have six times the risk of cardiac arrest than those with normal levels of bicarbonate.
Last year, amidst an increase in reported deaths related to GranuFlo, Fresenius sent out an internal memo to warn its company doctors about the extra bicarbonate. The Fresenius internal memo revealed that 941 patients had suffered cardiac arrests while receiving dialysis at Fresinius clinics. Shockingly, Fresenius chose not to warn non-company-owned facilities. As a result, more than 125,000 patients continued to use GranuFlo.
The FDA recently issued an Official Alert and Class I Recall notice to health care providers. The FDA aslo recommends that doctors immediately review their patient’s bicarbonate levels. The FDA also found that GranuFlo may cause serious adverse health consequences and even death.
If you have had any adverse problems, complications or side effect due to the use of GranuFlo or Naturalyte, contact a lawyers who sues for dialysis mistakes. I also reccomend that you report your experiences to the FDA’s MedWatch Safety Information and Adverse Event Reporting Program. Our dangerous medical device lawyers are investigating claims on behalf of patients who have used GranuFlo or NaturaLyte during dialysis and have suffered a cardiac event, heart attack or stroke. This information about Granuflo and Naturalyte should be of serious concern to any patient currently undergoing dialysis in the United States.